MarginsXMarginsX
Home › Markets › OSRH

OSR Health, Inc. (OSRH)

OSRH is quoted over the counter, not listed on an exchange. OSR Health, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.1165
+3.1% on the day
1-year return
-77.4%
Market cap
$4.1M
Nano cap. From the Nov 16, 2026 close × 35.3M shares (10-Q cover page, Nov 13, 2026)
P/E and P/S
Net loss over the period · 2.3×
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerOSRH, quoted over the counter
SEC CIK0001840425
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codeSurgical & Medical Instruments & Apparatus
Business addressBellevue, WA
Incorporated inDE

Warning signs

Cash runway
2.5 months
$1.5M cash at June 30, 2026
Share count, 1 year
+37.3%
2025-11-05 to 2026-11-13 · +289.4% over 3 years
Going-concern doubt
No
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-13
Cash and burn$1.5M cash; operating cash flow -$1.8M a quarter.Report 2026-06-30
Shares outstanding35,258,692 (2026-11-13); 25,672,788 a year earlier; 9,055,000 three years earlier.Cover page 2026-11-13
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months3 (8-K item 3.01)8-K 2026-10-28
Delisting25-NSE filed25-NSE 2025-02-18
AuditorWithumSmith+Brown, PC, New York, New York, United States; changed auditors 1 time in 24 months8-K 4.01 2026-11-13
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$316K-$1.0M-$2.4M$1.5M$2.6M$1.8M10-Q 2026-08-14
Q1 2026
2026-03-31
$484K-$3.5M-$1.0M$1.6M$2.7M$2.6M10-Q 2026-05-13
Q4 2025
2025-12-31
$381K-$7.2M-$1.1M$1.7M$2.3M$2.9M10-K 2026-03-31
Q3 2025
2025-09-30
$628K-$3.2M-$2.7M$2.2M$1.9M$3.4M10-Q 2025-11-12
Q2 2025
2025-06-30
$1.1M-$5.2M-$483K$1.6M$2.4M$3.6M10-Q 2026-08-14
Q1 2025
2025-03-31
$761K-$11.4M-$64K$1.6M$2.1M$3.4M10-Q 2026-05-13
Q4 2024
2024-12-31
$915K-$2.0M-$181K$342K$2.3M$3.5M10-K 2026-03-31
Q3 2024
2024-09-30
$823K-$231K-$686K$12K$3.9MNeeds four quarters10-Q 2025-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32025-06-27
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-11-13
Latest proxyDEF 14A2026-07-16

Source: SEC EDGAR submissions feed, 228 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier